Your browser doesn't support javascript.
loading
Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab.
Walraven, Maudy; Homs, Marjolein Y V; van der Veldt, Astrid A M; Dekker, Henk; Koldenhof, Jose; Honeywell, Richard; Barendrecht, Arjan; Sebastian, Silvie A E; Parr, Naomi; Koekman, Arnold C; Voest, Emile E; Roest, Mark; Korporaal, Suzanne J A; Verheul, Henk M W.
Afiliación
  • Walraven M; Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan, 1117, 1081 HV, Amsterdam, The Netherlands.
  • Homs MYV; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • van der Veldt AAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Dekker H; Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan, 1117, 1081 HV, Amsterdam, The Netherlands.
  • Koldenhof J; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Honeywell R; Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan, 1117, 1081 HV, Amsterdam, The Netherlands.
  • Barendrecht A; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Sebastian SAE; Department of Medical Oncology, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan, 1117, 1081 HV, Amsterdam, The Netherlands.
  • Parr N; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Koekman AC; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Voest EE; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Roest M; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Korporaal SJA; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Verheul HMW; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Angiogenesis ; 21(2): 325-334, 2018 05.
Article en En | MEDLINE | ID: mdl-29532289
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Plaquetas / Agregación Plaquetaria / Inhibidores de la Angiogénesis / Bevacizumab / Sorafenib / Sunitinib Idioma: En Revista: Angiogenesis Asunto de la revista: HEMATOLOGIA Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Plaquetas / Agregación Plaquetaria / Inhibidores de la Angiogénesis / Bevacizumab / Sorafenib / Sunitinib Idioma: En Revista: Angiogenesis Asunto de la revista: HEMATOLOGIA Año: 2018 Tipo del documento: Article